--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "CPS by CPhA" developer_entity: "Canadian Pharmacists Association (CPhA)" bundle_id: "ca.pharmacists.mobl" app_store_id: "428293181" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-03-25" report_date: "2026-08-31" last_verified: "2026-08-31T00:00:00.000Z" report_version: "8.0.2" total_reviews: 2 overall_rating: 1 confidence: "low" confidence_score: 0.05 data_age_days: 37 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "subscription", "mobile app", "app review", "app analysis", "health", "practitioners", "requiring"] canonical_url: "https://marlvel.ai/apps/cps-by-cpha" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # CPS by CPhA Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 1 > **TL;DR:** CPS by CPhA is a medical app by Canadian Pharmacists Association (CPhA), rated 1/5 by 2 users, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** CPS by CPhA is a medical app by Canadian Pharmacists Association (CPhA). ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 1/5 (2 reviews) | | **Category** | Medical | | **Developer** | Canadian Pharmacists Association (CPhA) | | **Pricing** | Subscription | | **Platforms** | iOS | | **Confidence** | Low (0.05/1.0) | | **Data Age** | 37d | ## Metadata & Market Performance - **Publisher:** Canadian Pharmacists Association (CPhA) - **Category:** Medical - **Target Audience:** Health care practitioners requiring evidence-based drug information and clinical decision support at the point-of-care. - **Platforms:** iOS - **Version Reviewed:** 8.0.2 - **Report Date:** 2026-08-31 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 428293181 - **Bundle ID:** ca.pharmacists.mobl - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-31 ## Executive Snapshot **What it is:** CPS by CPhA is a clinical drug information resource for Canadian health care practitioners, offering monographs and therapeutic algorithms via subscription on iOS. **Why users hire it:** The platform removes the cognitive cost of verifying drug information against Health Canada standards during patient consultations. ## App DNA (Features & Intent) - **[Standard] Drug Monographs:** Database of thousands of drug, vaccine, and medical device monographs approved by Health Canada. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Therapeutic Information and Algorithms:** Evidence-based therapeutic guidance and condition-based drug tables. - **[Standard] Medical Calculators:** Integrated tools for clinical calculations at the point-of-care. ## Market Position {#market-position} CPS by CPhA maintains a niche position as the Canadian standard for drug monographs, yet the 1-star rating across the current user base suggests the platform is failing to meet professional expectations. ## Monetization Strategy - **Model:** Subscription - **Tiers:** CPS Drug Information subscription, CPS Full Access subscription - **Analysis:** Subscription model segments users by clinical depth, gating advanced therapeutic algorithms behind the Full Access tier. ## SWOT Analysis {#swot} **Core Strengths:** - Health Canada-approved monograph database creates a regulatory-backed barrier to entry **Growth Levers:** - Offline-first access for critical drug tables would improve utility in clinical settings ## Recent Changes (v2 → v3) {#recent-changes} The emergence of a 1-star rating and associated technical instability has shifted the platform's outlook from neutral to declining. This change highlights a critical gap between the app's regulatory-backed content and its current functional reliability. **Overall trend**: Declining **Compared at**: 2026-08-31 ### High-impact changes - **[Declined] Emergence of 1-star rating** (sentiment) - **[Added] New technical and professional risks** (swot) ### Medium-impact changes - **[Shifted] Pivot to stability-focused audit** (positioning) ## What's New - **Latest (v8.0.2, 5 months ago):** Maintenance update focused on minor enhancements and bug fixes. ## App Momentum (Maintenance) {#momentum} - Maintenance-only release cadence for 5 months. - No new features in latest release. > **Cadence:** 1 total versions · 0 majors in last 6 months · 159 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} CPS by CPhA is a medical app. It holds a 1/5 rating from 2 reviews. > **Bottom Line:** Prioritizing a stability-focused release cycle would address the critical usability failures currently driving the 1-star rating, which is the primary barrier to professional adoption. **Best for:** Health care practitioners requiring evidence-based drug information and clinical decision support at the point-of-care. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] Audit stability in the latest release because the 1-star rating indicates critical usability failures → restore professional trust ### Outlook: Declining The clinical reference market is shifting toward high-frequency update cycles to match evolving therapeutic guidelines. CPS by CPhA's current maintenance-only posture risks professional churn, as the 1-star rating suggests the platform is no longer meeting the reliability requirements of its target audience. - 🔴 The 159-day gap since the latest release indicates a maintenance-only posture that leaves the app vulnerable to more agile clinical reference tools. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 1/5 | | Total Reviews | 2 | | Confidence | Low | | Pricing Model | Subscription | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **CPS by CPhA** (this app) | 1/5 | N/A | Canadian Pharmacists Association (CPhA) | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Canadian Pharmacists Association (CPhA) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/cps-by-cpha/id428293181?uo=4) - **Sources:** App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 37 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/cps-by-cpha) Data licensed for AI Agent attribution under CC-BY-NC 4.0.